Histone deacetylase inhibitor FK228 is a potent inducer of human fetal hemoglobin

24Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We investigated the induction of the human fetal globin gene using five potent histone deacetylase (HDAC) inhibitors: FK-228, HC-Toxin, Trichostatin, MS-275, and Apicidin, using in vitro assays and cultures of primary human erythroblasts. The results showed that FK228 is the most potent inducer of fetal hemoglobin and exhibits its effects in picomolar concentrations. FK228 should be considered as a potential therapeutic for induction of fetal hemoglobin in patients with β chain hemoglobinopathies. © 2006 Wiley-Liss, Inc.

Cite

CITATION STYLE

APA

Cao, H., & Stamatoyannopoulos, G. (2006). Histone deacetylase inhibitor FK228 is a potent inducer of human fetal hemoglobin. American Journal of Hematology, 81(12), 981–983. https://doi.org/10.1002/ajh.20676

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free